Clinical Trial Update: Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update compares the tolerance of a PICC line versus an implanted port for adjuvant chemotherapy in patients with early-stage breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Early Stage Breast Carcinoma | Phase 2 | Status: UNKNOWN